Faeth Therapeutics Inc (FTH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2020 | 12-2019 | 12-2017 | 12-2006 | |
| Operating Expenses | 19,451 | 12,435 | 0 | 0 |
| Operating Income | -19,451 | -12,435 | N/A | N/A |
| Interest Expense | 1,689 | 2,256 | 0 | 0 |
| Other Income | 1,040 | -2,049 | 0 | 0 |
| Pre-tax Income | -20,100 | -16,740 | 0 | 0 |
| Net Income Continuous | -20,100 | -16,740 | N/A | N/A |
| Net Income | $-20,100 | $-16,740 | $N/A | $N/A |
| EPS Basic Total Ops | -250.60 | -1,118.40 | N/A | N/A |
| EPS Basic Continuous Ops | -249.38 | -911.37 | N/A | N/A |
| EPS Diluted Total Ops | -250.60 | -1,118.40 | N/A | N/A |
| EPS Diluted Continuous Ops | -249.38 | -911.37 | N/A | N/A |
| EPS Diluted Before Non-Recurring Items | -250.60 | N/A | N/A | N/A |
| EBITDA(a) | $-17,664 | $-10,968 | $N/A | $N/A |